CAS 2169916-18-9

Formula: C32H47FN6O4S

InChI: InChI=1S/C32H47FN6O4S/c1-22(2)39(23(3)4)31(40)27-16-25(33)8-11-28(27)43-29-17-34-21-35-30(29)38-19-32(20-38)12-14-37(15-13-32)18-24-6-9-26(10-7-24)36-44(5,41)42/h8,11,16-17,21-24,26,36H,6-7,9-10,12-15,18-20H2,1-5H3

InChI key: ADHHOUXZPBYYSU-UHFFFAOYSA-N

SMILES: CC(C)N(C(C)C)C(=O)C1=C(C=CC(=C1)F)OC2=CN=CN=C2N3CC4(C3)CCN(CC4)CC5CCC(CC5)NS(=O)(=O)C

VTP50469

CAS: 2169916-18-9

VTP50469

Formula: C₃₂H₄₇FN₆O₄S

Purity: ≥98%

Molecular weight: 630.82

Ref: 54-BUP04479

VTP50469

CAS: 2169916-18-9

VTP50469 is a highly selective and orally active small molecule inhibitor of the Menin-MLL protein-protein interaction.Cost-effective and quality-assured.

Formula: C₃₂H₄₇FN₆O₄S

Purity: 98.31% - 99.65%

Color and Shape: Solid

Molecular weight: 630.817

Ref: TM-T13336

VTP50469

CAS: 2169916-18-9

Formula: C₃₂H₄₇FN₆O₄S

Color and Shape: Solid

Molecular weight: 630.8168

Ref: IN-DA01V2O5

VTP50469

CAS: 2169916-18-9

5-Fluoro-N,N-diisopropyl-2-((4-(7-((trans-4-(methylsulfonamido)cyclohexyl)methyl)-2,7-diazaspiro[3.5]nonan-2-yl)pyrimidin-5-yl)oxy)benzamide

Formula: C₃₂H₄₇FN₆O₄S

Purity: 98%

Molecular weight: 630.82

Ref: IN-DG01347060

VTP50469

CAS: 2169916-18-9

VTP50469 is a synthetic analogue of the fatty acid cay10666, which has been shown to inhibit the proliferation of leukemia cells in vitro. VTP50469 is also effective against cancer cell lines derived from various organs, including carcinoma cell lines and epidermal growth factor-secreting cells. The mechanism of action of VTP50469 may be related to its ability to interact with DNA polymerase during DNA synthesis or replication, resulting in inhibition of the enzyme's activity. The effect of VTP50469 can be synergistic with other chemotherapeutic agents such as cisplatin, doxorubicin, and vincristine. This drug has also been shown to have anti-angiogenic properties and inhibit tumor growth in vivo.

Formula: C₃₂H₄₇FN₆O₄S

Purity: Min. 95%

Molecular weight: 630.8 g/mol

Ref: 3D-ULD91618